Using antidepressants and the risk of stroke recurrence: Report from a national representative cohort study

BMC Neurology

Volumn 15, Issue 1, 2015, Pages

  Juang, Hsiao Ting ^a,b   Chen, Pei Chun ^c   Chien, Kuo Liong ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; RECURRENCE RISK; RECURRENT DISEASE; TAIWAN; CEREBRAL HEMORRHAGE; CHEMICALLY INDUCED; COMORBIDITY; COMPLICATION; DIABETES MELLITUS; MIDDLE AGED; REGISTER; RISK; STATISTICS AND NUMERICAL DATA; STROKE;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; COMORBIDITY; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RECURRENCE; REGISTRIES; RISK; STROKE; TAIWAN;

EID: 84930647812     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/s12883-015-0345-x     Document Type: Article

References (32)

1. World Health Organization: The Global Burden of Disease: 2004 Update.
2. Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg. 2011;76:S85-90.
3. Tseng MC, Lin HJ. Readmission after hospitalization for stroke in Taiwan: results from a national sample. J Neurol Sci. 2009;284:52-5.
4. Samsa GP, Bian J, Lipscomb J, Matchar DB. Epidemiology of recurrent cerebral infarction: a medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost. Stroke. 1999;30:338-49.
5. Chen Y, Patel NC, Guo JJ, Zhan S. Antidepressant prophylaxis for poststroke depression: a meta-analysis. Int Clin Psychopharmacol. 2007;22:159-66.
6. Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011;10:123-30.
7. Mikami K, Jorge RE, Adams HP, Davis PH, Leira EC, Jang M, et al. Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatr. 2011;19:1007-15.
8. Hackett ML, Anderson CS, House AO, Xia J. Interventions for treating depression after stroke. Stroke. 2009;40:e487-8.
9. Mead GE, Hsieh CF, Lee R, Kutlubaev MA, Claxton A, Hankey GJ, et al. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev. 2012;11:CD009286.
10. Wu CS, Wang SC, Cheng YC, Gau SS. Association of cerebrovascular events with antidepressant use: a case-crossover study. Am J Psychiatry. 2011;168:511-21.
11. Yuan HW, Wang CX, Zhang N, Bai Y, Shi YZ, Zhou Y, et al. Poststroke depression and risk of recurrent stroke at 1 year in a Chinese cohort study. PLoS One. 2012;7:e46906.
12. Mortensen JK, Larsson H, Johnsen SP, Andersen G. Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up study. Stroke. 2013;44:420-6.
13. Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA. 2011;306:1241-9.
14. Pequignot R, Tzourio C, Peres K, Ancellin ML, Perier MC, Ducimetière P, et al. Depressive symptoms, antidepressants and disability and future coronary heart disease and stroke events in older adults: the Three City Study. Eur J Epidemiol. 2013;28:249-56.
15. WHOCC ATC/DDD Index. http://www.whocc.no/atc_ddd_index/ .
16. Simon R, Makuch RW. A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias. Stat Med. 1984;3:35-44.
17. Schultz LR, Peterson EL, Breslau N. Graphing survival curve estimates for time-dependent covariates. Int J Methods Psychiatr Res. 2002;11:68-74.
18. Muhonen MG, Robertson SC, Gerdes JS, Loftus CM. Effects of serotonin on cerebral circulation after middle cerebral artery occlusion. J Neurosurg. 1997;87:301-6.
19. Razzaque Z, Heald MA, Pickard JD, Maskell L, Beer MS, Hill RG, et al. Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation. Br J Clin Pharmacol. 1999;47:75-82.
20. Ramasubbu R. Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review. J Clin Psychiatr. 2004;65:1642-53.
21. Schlienger RG, Meier CR. Effect of selective serotonin reuptake inhibitors on platelet activation: can they prevent acute myocardial infarction? Am J Cardiovasc Drugs. 2003;3:149-62.
22. Maurer-Spurej E, Pittendreigh C, Solomons K. The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thromb Haemost. 2004;91:119-28.
23. Hackam DG, Mrkobrada M. Selective serotonin reuptake inhibitors and brain hemorrhage A meta-analysis. Neurology. 2012;79:1862-5.
24. Kharofa J, Sekar P, Haverbusch M, Moomaw C, Flaherty M, Kissela B, et al. Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke. 2007;38:3049-51.
25. Bak S, Tsiropoulos I, Kjaersgaard JO, Andersen M, Mellerup E, et al. Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke. 2002;33:1465-73.
26. Douglas I, Smeeth L, Irvine D. The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study. Br J Clin Pharmacol. 2011;71:116-20.
27. Caughey GE, Preiss AK, Vitry AI, Gilbert AL, Ryan P, Shakib S, et al. Does antidepressant medication use affect persistence with diabetes medicines? Pharmacoepidemiol Drug Saf. 2013;22:615-22.
28. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836-41.
29. Wu CS, Shau WY, Chan HY, Lee YC, Lai YJ, Lai MS. Utilization of antidepressants in Taiwan: a nationwide population-based survey from 2000 to 2009. Pharmacoepidemiol Drug Saf. 2012;21:980-8.
30. de Abajo FJ, Gil MJ, Bryant V, Timoner J, Oliva B, García-Rodríguez LA. Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database. Eur J Clin Pharmacol. 2013;69:691-701.
31. Moride Y, Abenhaim L. Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research. J Clin Epidemiol. 1994;47:731-7.
32. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20:236-42.